Skip to main content

and
  1. No Access

    Article

    Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result

    This study compared virologic response to entecavir monotherapy and de novo lamivudine plus adefovir (LAM + ADV) combination therapy in patients with chronic hepatitis B (CHB) with high viral load (HVL). Hepa...

    Shaohang Cai, Tao Yu, Yegui Jiang, Yonghong Zhang in Clinical and Experimental Medicine (2016)